NCT01698008

Brief Summary

Adult patients with diabetes on insulin are eligible for the study. They will be randomized to a group using standard of care communication and a group using an I phone intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable diabetes-mellitus

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 28, 2012

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 28, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 2, 2012

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2013

Completed
5.1 years until next milestone

Results Posted

Study results publicly available

November 2, 2018

Completed
Last Updated

October 17, 2023

Status Verified

October 1, 2023

Enrollment Period

1.7 years

First QC Date

September 28, 2012

Results QC Date

January 29, 2018

Last Update Submit

October 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evidence for Improved Diabetic Care With Mobile Phone Application Use

    Satisfaction and usability was evaluated with a survey for those subjects who used the mobile phone application at the 3 and 6 months period.

    Six months

Study Arms (2)

Mobile application Diabetes Doctor

EXPERIMENTAL

The intervention group will send in blood glucoses once a month using the mobile phone app, Diabetes Doctor. All subjects will be evaluated at initial, 3 month, and 6 month visits. They will receive HbA1c on each visit. After 3 months, a Diabetes Quality of Life (QOL) survey will be completed. A Usability and Satisfaction of Diabetes Doctor (USDD) survey will also be obtained. At the 3 month visit, they will also be given the chance to discontinue the mobile app and switch to standard of care. At 6 months, all mobile app users will complete the USDD and satisfaction and QOL survey. If they are not using the mobile app, then they will complete the QOL survey.

Other: Diabetes Doctor Mobile app

Standard of Care

NO INTERVENTION

The standard of care arm will not use the mobile application Diabetes Doctor to communicate with their physician about their blood sugars. They will attend clinic visits and have evaluations initially, and at 3 and 6 months. They will also receive a HbAIc at each visit. They will do the same QOL survey at 3 months. At 6 months, they will be given the QOL survey.

Interventions

Diabetes Doctor is a mobile application software. The mobile phone application allows a subject to register blood glucose values obtained from their fingerstick glucose meter readings, the type and amount of insulin they are administering, any notes they would like to document, and the date and time of each entry. All data will be entered by the subject manually. The data will be submitted through encryption coded private servers and can be retrievable by a physician on a password protected website for privacy. A physician will evaluate this information to recommend a change of the subject's insulin regimen. The recommended insulin regimen will be delivered to the patient using the same website and received by the subject on the same mobile application software.

Mobile application Diabetes Doctor

Eligibility Criteria

Age19 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 or type 2 Diabetes Mellitus on insulin basal/bolus injection
  • Own and are able to operate an iPhone

You may not qualify if:

  • Type 2 diabetics using only oral medications
  • Do not own or know how to operate an iPhone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Limitations and Caveats

Overall, there were difficulties with this study. We only had a small number of patients interested in participating and those that were given standard of care treatment did not continue on with the study.

Results Point of Contact

Title
Whitney Goldner
Organization
University of Nebraska Medical Center

Study Officials

  • Whitney S Goldner, MD

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: One group is standard of care. The other is given the opportunity to use a new mobile app for reporting blood sugars.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2012

First Posted

October 2, 2012

Study Start

January 28, 2012

Primary Completion

September 25, 2013

Study Completion

September 25, 2013

Last Updated

October 17, 2023

Results First Posted

November 2, 2018

Record last verified: 2023-10

Locations